Trial
NCT01098656
Lenalidomide Maintenance Post-debulking in Advanced CTCL
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
—
Condition
Lymphoma
Intervention
lenalidomide
Why stopped
recruitment prematurely halted following company's decision to stop financial support to the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-09